ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
11,013,755
Share change
+2,995,554
Total reported value
$241,353,000
Price per share
$21.88
Number of holders
38
Value change
+$65,737,809
Number of buys
24
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q1 2015

As of 31 Mar 2015, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,013,755 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, Clearbridge Investments, LLC, Viking Global Investors LP, BAKER BROS. ADVISORS LP, and FRANKLIN RESOURCES INC. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.